Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug, Radiation
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
To evaluate the efficacy and safety of Spirulina-Derived Product for prevention and treatment of oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients pathologically diagnosed with non-metastatic head and neck malignant tumors;
• Aged ≥ 18 years;
• Eastern Cooperative Oncology Group performance status of ≤2;
• Receiving definitive RT or postoperative adjuvant RT at a dose of 60- 72 Gy with/without concurrent chemotherapy;
• Sign informed consent.
Locations
Other Locations
China
West China Hospital, Sichuan University
RECRUITING
Chengdu
Contact Information
Primary
Xingchen Peng, Professor
pxx2014@163.com
+8618980606753
Backup
Yiyan Pei, Doctor
pei_yiyan@163.com
+86 19382124852
Time Frame
Start Date: 2025-06-27
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 70
Treatments
Placebo_comparator: Control group
Spray of placebo
Experimental: Experimental group
Spray of spirulina derivatives
Related Therapeutic Areas
Sponsors
Leads: West China Hospital